Ibrance (palbociclib) - Pfizer
Ibrance: Data from P3 PENELOPE-B trial (NCT01864746) for breast cancer in late 2020 (Pfizer) - Jan 28, 2020 - Q4 2019 Results 
P3 data
https://s21.q4cdn.com/317678438/files/doc_financials/2019/q4/Q4-2019-Earnings-Charts-FINAL.pdf
 
Jan 28, 2020
 
 
26abc2b1-f338-40e7-b7a0-7328f3bdbfde.png